Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
This could be monthly injections for those with absorption issues, or less frequently if you're just topping up levels
The cautious approach: Until more research exists, individuals with active cancer, cancer history, or genetic predisposition should avoid BPC-157
Avoid Over-Dilution: Adding too much water (e.g., 10 mL to a 2 mg vial) results in a dilute solution, requiring larger injection volumes that may be impractical or uncomfortable
Those are legitimate reasons to offer them
Keep away from direct light
However, retatrutide has not received approval from the MHRA or the EMA and remains an investigational agent undergoing Phase 3 trials
US$ 27.62
US$ 21.86
US$ 22.47
US$ 28.25
US$ 27.12
